Hyperbaric oxygenation modulates vascular reactivity to angiotensin-(1-7) in diabetic rats: Potential role of epoxyeicosatrienoic acids

Diabetes and Vascular Disease Research

Volumn 12, Issue 1, 2015, Pages 33-45

  Kibel, Aleksandar ^a   Novak, Sanja ^a   Cosic, Anita ^a   Mihaljevic, Zrinka ^a   Falck, John R ^b   Drenjancevic, Ines ^a  

^a JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

angiotensin II; angiotensin (1 7); epoxyeicosatrienoic acids; Hyperbaric oxygen therapy

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN[1-7]; CYTOCHROME; CYTOCHROME P450; CYTOCHROME P450 2C11; CYTOCHROME P450 4A1; CYTOCHROME P450 4A2; CYTOCHROME P450 4A3; EPOXYICOSATRIENOIC ACID; GLUCOSE; MESSENGER RNA; NORADRENALIN; OXIDOREDUCTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; AMIDE; ANGIOTENSIN I; ANGIOTENSIN I (1-7); CYP2C11 PROTEIN, RAT; CYP2J3 PROTEIN, RAT; DIHOMO GAMMA LINOLENIC ACID; ENZYME INHIBITOR; N-METHYLSULFONYL-6-(2-PROPARGYLOXYPHENYL)HEXANAMIDE; PEPTIDE FRAGMENT; STEROID 16ALPHA MONOOXYGENASE; UNSPECIFIC MONOOXYGENASE; VASODILATOR AGENT;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HYPERBARIC OXYGEN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR RING; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMISTRY; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DRUG EFFECTS; ENZYME INDUCTION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; THORACIC AORTA; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

8,11,14-EICOSATRIENOIC ACID; AMIDES; ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ENZYME INDUCTION; ENZYME INHIBITORS; HYPERBARIC OXYGENATION; MALE; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; RATS, SPRAGUE-DAWLEY; STEROID 16-ALPHA-HYDROXYLASE; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 84916908601     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164114553424     Document Type: Article

References (74)

1. Drenjancevic I, Kibel A. Restoring vascular function with hyperbaric oxygen treatment: recovery mechanisms. J Vasc Res. 2014 ; 51: 1-13
2. Tandara AA, Mustoe TA. Oxygen in wound healing - more than a nutrient. World J Surg. 2004 ; 28: 294-300
3. Kudchodkar BJ, Wilson J, Lacko A, et al. Hyperbaric oxygen reduces the progression and accelerates the regression of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol. 2000 ; 20: 1637-1643
4. Kudchodkar BJ, Pierce A, Dory L. Chronic hyperbaric oxygen treatment elicits an anti-oxidant response and attenuates atherosclerosis in apoE knockout mice. Atherosclerosis. 2007 ; 193: 28-35
5. Camporesi EM Hyperbaric oxygen therapy: committee report. Kensington, MD: Undersea and Hyperbaric Medical Society ; 1996: 74.
6. Bakker DJ. Hyperbaric oxygen therapy and the diabetic foot. Diabetes Metab Res Rev. 2000 ; 16: S55 - S58
7. Kibel A, Cavka A, Cosic A, et al. Effects of hyperbaric oxygenation on vascular reactivity to angiotensin II and angiotensin-(1-7) in rats. Undersea Hyperb Med. 2012 ; 39: 1053-1066
8. Yousif MH, Dhaunsi GS, Makki BM, et al. Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes. Pharmacol Res. 2012 ; 66: 269-275
9. Yousif MH, Benter IF, Roman RJ. Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury. Auton Autacoid Pharmacol. 2009 ; 29: 33-41
10. Benter IF, Yousif MH, Cojocel C, et al. Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction. Am J Physiol Heart Circ Physiol. 2007 ; 292: H666 - H672
11. Rodgers K, Verco S, Bolton L, et al. Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7). Expert Opin Investig Drugs. 2011 ; 20: 1575-1581
12. Chen G, Xu R, Wang Y, et al. Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy. Am J Physiol Endocrinol Metab. 2012 ; 303: E563 - E575
13. Theken KN, Schuck RN, Edin ML, et al. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease. Atherosclerosis. 2012 ; 222: 530-536
14. Jouihan SA, Zuloaga KL, Zhang W, et al. Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus. J Cereb Blood Flow Metab. 2013 ; 33: 1650-1656
15. Pieper GM. Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension. 1998 ; 31: 1047-1060
16. Katusic ZS. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?. Am J Physiol Heart Circ Physiol. 2001 ; 281: H981 - H986
17. Hink U, Li H, Mollnau H, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 2001 ; 88: E14 - E22
18. Zenere BM, Arcaro G, Saggiani F, et al. Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria. Diabetes Care. 1995 ; 18: 975-982
19. Gazis A, White DJ, Page SR, et al. Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus. Diabet Med. 1999 ; 16: 304-311
20. Bagi Z, Koller A. Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin. J Vasc Res. 2003 ; 40: 47-57
21. Benter IF, Yousif MH, Canatan H, et al. Inhibition of Ca2+/calmodulin-dependent protein kinase II, RAS-GTPase and 20-hydroxyeicosatetraenoic acid attenuates the development of diabetes-induced vascular dysfunction in the rat carotid artery. Pharmacol Res. 2005 ; 52: 252-257
22. Bentsen N, Larsen B, Lassen NA. Chronically impaired autoregulation of cerebral blood flow in long-term diabetics. Stroke. 1975 ; 6: 497-502
23. Lash JM, Bohlen HG. Structural and functional origins of suppressed acetylcholine vasodilation in diabetic rat intestinal arterioles. Circ Res. 1991 ; 69: 1259-1268
24. Sartoretto JL, Melo GA, Carvalho MH, et al. Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression. Life Sci. 2005 ; 77: 2676-2689
25. Ungvari Z, Pacher P, Kecskemeti V, et al. Increased myogenic tone in skeletal muscle arterioles of diabetic rats. Possible role of increased activity of smooth muscle Ca2+ channels and protein kinase C. Cardiovasc Res. 1999 ; 43: 1018-1028
26. Savage MW, Bodmer CW, Walker AB, et al. Vascular reactivity to noradrenaline and neuropeptide Y in the streptozotocin-induced diabetic rat. Eur J Clin Invest. 1995 ; 25: 974-979
27. Zhao X, Imig JD. Kidney CYP450 enzymes: biological actions beyond drug metabolism. Curr Drug Metab. 2003 ; 4: 73-84
28. Alkayed NJ, Birks EK, Hudetz AG, et al. Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow. Am J Physiol. 1996 ; 271: H1541 - H1546
29. Liclican EL, Doumad AB, Wang J, et al. Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensive. Hypertension. 2009 ; 54: 1284-1290
30. Pozzi A, Macias-Perez I, Abair T, et al. Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipids. J Biol Chem. 2005 ; 280: 27138-27146
31. Xu X, Zhang XA, Wang DW. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases. Adv Drug Deliv Rev. 2011 ; 63: 597-609
32. Wang MH, Brand-Schieber E, Zand BA, et al. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J Pharmacol Exp Ther. 1998 ; 284: 966-973
33. Lianos EA Eicosanoid protocols. Totowa, NJ: Springer (Humana Press) ; 1999:
34. Chen G, Wang P, Zhao G, et al. Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice. Prostaglandins Other Lipid Mediat. 2011 ; 96: 63-71
35. Harder DR, Narayanan J, Birks EK, et al. Identification of a putative microvascular oxygen sensor. Circ Res. 1996 ; 79: 54-61
36. Kerkhof CJ, Bakker EN, Sipkema P. Role of cytochrome P-450 4A in oxygen sensing and NO production in rat cremaster resistance arteries. Am J Physiol. 1999 ; 277: H1546 - H1552
37. Baragatti B, Ciofini E, Scebba F, et al. Cytochrome P-450 3A13 and endothelin jointly mediate ductus arteriosus constriction to oxygen in mice. Am J Physiol Heart Circ Physiol. 2011 ; 300: H892 - H901
38. Brand-Schieber E, Falck JF, Schwartzman M. Selective inhibition of arachidonic acid epoxidation in vivo. J Physiol Pharmacol. 2000 ; 51: 655-672
39. Grobe JL, Katovich MJ. Alterations in aortic vascular reactivity to angiotensin 1-7 in 17-beta-estradiol-treated female SD rats. Regul Pept. 2006 ; 133: 62-67
40. Zhi JM, Chen RF, Wang J, et al. Comparative studies of vasodilating effects of angiotensin-(1-7) on the different vessels. Sheng li xue bao. 2004 ; 56: 730-734
41. Do KH, Kim MS, Kim JH, et al. Angiotensin II-induced aortic ring constriction is mediated by phosphatidylinositol 3-kinase/L-type calcium channel signaling pathway. Exp Mol Med. 2009 ; 41: 569-576
42. Boegehold MA. Microvascular structure and function in salt-sensitive hypertension. Microcirculation. 2002 ; 9: 225-241
43. Falcone JC, Granger HJ, Meininger GA. Enhanced myogenic activation in skeletal muscle arterioles from spontaneously hypertensive rats. Am J Physiol. 1993 ; 265: H1847 - H1855
44. Higashi Y, Sasaki S, Nakagawa K, et al. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002 ; 346: 1954-1962
45. Mayhan WG, Faraci FM, Heistad DD. Impairment of endothelium-dependent responses of cerebral arterioles in chronic hypertension. Am J Physiol. 1987 ; 253: H1435 - H1440
46. Swei A, Lacy F, DeLano FA, et al. Oxidative stress in the Dahl hypertensive rat. Hypertension. 1997 ; 30: 1628-1633
47. Zicha J, Dobesova Z, Kunes J. Relative deficiency of nitric oxide-dependent vasodilation in salt-hypertensive Dahl rats: the possible role of superoxide anions. J Hypertens. 2001 ; 19: 247-254
48. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of 'antioxidant power': the FRAP assay. Anal Biochem. 1996 ; 239: 70-76
49. Oakes KD, Van Der Kraak GJ. Utility of the TBARS assay in detecting oxidative stress in white sucker (Catostomus commersoni) populations exposed to pulp mill effluent. Aquat Toxicol. 2003 ; 63: 447-463
50. Charlton SJ. Agonist efficacy and receptor desensitization: from partial truths to a fuller picture. Br J Pharmacol. 2009 ; 158: 165-168
51. Oliveira L, Costa-Neto CM, Nakaie CR, et al. The angiotensin II AT1 receptor structure-activity correlations in the light of rhodopsin structure. Physiol Rev. 2007 ; 87: 565-592
52. Silva DM, Gomes-Filho A, Olivon VC, et al. Swimming training improves the vasodilator effect of angiotensin-(1-7) in the aorta of spontaneously hypertensive rat. J Appl Physiol (1985). 2011 ; 111: 1272-1277
53. Kluskens LD, Nelemans SA, Rink R, et al. Angiotensin-(1-7) with thioether bridge: an angiotensin-converting enzyme-resistant, potent angiotensin-(1-7) analog. J Pharmacol Exp Ther. 2009 ; 328: 849-854
54. Kilarkaje N, Yousif MH, El-Hashim AZ, et al. Role of angiotensin II and angiotensin-(1-7) in diabetes-induced oxidative DNA damage in the corpus cavernosum. Fertil Steril. 2013 ; 100: 226-233
55. Giani JF, Burghi V, Veiras LC, et al. Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats. Am J Physiol Renal Physiol. 2012 ; 302: F1606 - F1615
56. Neckar J, Kopkan L, Huskova Z, et al. Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension. Clin Sci. 2012 ; 122: 513-525
57. Cai Z, Zhao G, Yan J, et al. CYP2J2 overexpression increases EETs and protects against angiotensin II-induced abdominal aortic aneurysm in mice. J Lipid Res. 2013 ; 54: 1448-1456
58. Wang HX, Zhang DM, Zeng XJ, et al. Upregulation of cytochrome P450 2J3/11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway. Cytokine. 2012 ; 60: 360-368
59. Ying CJ, Noguchi T, Aso H, et al. The role of cytochrome p-450 in salt-sensitive stroke in stroke-prone spontaneously hypertensive rats. Hypertens Res. 2008 ; 31: 1821-1827
60. Drenjancevic-Peric I, Gros M, Kibel A. Influence of hyperbaric oxygen on blood vessel reactivity: concept of changes in conducted vasomotor response. Coll Antropol. 2009 ; 33: 681-685
61. Ngo AT, Jensen LJ, Riemann M, et al. Oxygen sensing and conducted vasomotor responses in mouse cremaster arterioles in situ. Pflugers Arch. 2010 ; 460: 41-53
62. Moon JY, Tanimoto M, Gohda T, et al. Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice. Am J Physiol Renal Physiol. 2011 ; 300: F1271 - F1282
63. Al-Waili NS, Butler GJ, Beale J, et al. Influences of hyperbaric oxygen on blood pressure, heart rate and blood glucose levels in patients with diabetes mellitus and hypertension. Arch Med Res. 2006 ; 37: 991-997
64. Bergo GW, Tyssebotn I. Cerebral blood flow distribution during exposure to 5 bar oxygen in awake rats. Undersea Biomed Res. 1992 ; 19: 339-354
65. Demchenko IT, Luchakov YI, Moskvin AN, et al. Cerebral blood flow and brain oxygenation in rats breathing oxygen under pressure. J Cereb Blood Flow Metab. 2005 ; 25: 1288-1300
66. Nagatomo F, Fujino H, Takeda I, et al. Effects of hyperbaric oxygenation on blood pressure levels of spontaneously hypertensive rats. Clin Exp Hypertens. 2010 ; 32: 193-197
67. Bergo GW, Risberg J, Tyssebotn I. Effect of 5 bar oxygen on cardiac output and organ blood flow in conscious rats. Undersea Biomed Res. 1988 ; 15: 457-470
68. Nakada T, Koike H, Katayama T, et al. Increased adrenal epinephrine and norepinephrine in spontaneously hypertensive rats treated with hyperbaric oxygen. Hinyokika kiyo/Acta urologica Japonica. 1984 ; 30: 1357-1366
69. Drenjancevic I, Kibel A, Kibel D, et al. Blood pressure, acid-base and blood gas status and indicators of oxidative stress in healthy male rats exposed to acute hyperbaric oxygenation. Undersea Hyperb Med. 2013 ; 40: 319-328
70. Khaidarova G, Borukhova ES, Asinova MI. Effect of hyperbaric oxygenation on the status of the renin-angiotensin-aldosterone system in chronic circulatory insufficiency in elderly patients with ischemic heart disease. Anesteziol Reanimatol. 1989 ; 3: 33-35
71. Pakharukova NA, Pastushkova L, Popova YA, et al. Study of normal human serum proteomic profile under conditions of hyperbaric oxygen-nitrogen-argon exposure. Bull Exp Biol Med. 2010 ; 149: 37-39
72. Walker BR, Hong SK, Mookerjee BK, et al. Suppressed renin release during hyperoxia in the conscious dog. Undersea Biomed Res. 1981 ; 8: 137-145
73. Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pr. 2014 ; 103: 137-149
74. Schnell O, Cappuccio F, Genovese S, et al. Type 1 diabetes and cardiovascular disease. Cardiovasc Diabetol. 2013 ; 12: 156